虚拟实境在治疗领域的市场－全球产业规模、份额、趋势、机会及预测（按技术、设备、应用、地区和竞争格局划分，2021-2031年）

全球治疗性虚拟实境市场预计将从 2025 年的 33.1 亿美元大幅成长至 2031 年的 74.7 亿美元，复合年增长率达 14.53%。

此领域利用身临其境型数位类比技术辅助身体復健、缓解疼痛，并应对焦虑和创伤后压力症候群（PTSD）等心理健康挑战。其发展的主要驱动力是慢性病盛行率的上升以及对扩充性、非侵入性治疗方法的迫切需求，这些方案能够减轻传统医疗系统的负担。此外，这些身临其境型工具与远端医疗基础设施的日益融合，提高了病患的就医便利性和参与度，使这项技术成为现代医疗保健体系的关键组成部分。

儘管市场呈现上升趋势，但仍面临许多挑战，尤其是采购专用硬体和开发临床检验软体的高昂成本。这些财务障碍，加上复杂的报销体系，可能会减缓小规模医疗机构的采用速度。然而，业内人士的信心依然强劲。 XR协会报告称，84%的医疗专业人士预测，虚拟实境（VR）和扩增实境（AR）技术将在2024年成为推动产业变革的积极力量。这种普遍的乐观情绪凸显了身临其境型治疗方法的持久价值，即便麵临经济和营运上的挑战。

市场驱动因素

临床检验和监管核准的不断增加正在从根本上改变市场格局，使虚拟实境技术从辅助手段跃升为公认的医疗干预手段。随着监管机构制定更清晰的核准流程，医疗专业人员越来越有信心将身临其境型疗法应用于各种用途，从术前准备到疼痛缓解。获批解决方案数量的不断增长也印证了这一发展势头。根据《放射学商业》（Radiology Business）2024年9月刊报道，美国FDA已核准69种采用扩增实境（AR）或虚拟实境（VR）技术的医疗产品，这标誌着监管环境日趋成熟，将有助于更广泛地接受这些技术。此类核准对于消除临床医生和保险公司的疑虑，并迅速将这些设备纳入标准治疗通讯协定至关重要。

此外，政府津贴和企业对数位疗法的投资激增，正助力企业拓展业务和技术能力，加速市场扩张。这笔资金注入使企业能够整合资产、扩大临床覆盖范围，并打造先进的人工智慧驱动型个人化医疗功能。例如，根据MedCity News在2024年1月报道，XRHealth公司已成功资金筹措600万美元，用于与Amelia Virtual Care合併，开发基于人工智慧的临床医生，从而建立一个涵盖身心健康的综合平台。这笔资金对于进行大规模临床试验至关重要，而这些试验对于验证疗效和获得医疗保险报销必不可少。 AppliedVR在2024年发布的报告显示，70%的严重慢性疼痛患者在接受治疗后疼痛强度有所减轻，这便是支持这项投资的临床成功案例，凸显了这些技术的切实益处。

市场挑战

治疗性虚拟实境市场面临的主要障碍是部署专用硬体和开发经临床检验的软体所需的高昂成本。身临其境型治疗应用需要精密的头戴式显示器和强大的计算能力，以确保疗效和患者安全，这导致前期投入巨大。对于许多独立诊所和小规模医疗机构而言，这些前期投资往往构成障碍，实际上阻碍了他们获得创新工具。此外，维护和更新复杂的数位基础设施所需的持续资源也加剧了这种经济负担，导致只有资金雄厚的大型机构才能采用此类技术。

因此，这些经济限制直接限制了虚拟实境疗法在整个医疗保健生态系统中广泛应用的潜力。行业调查也反映了这种投资意愿不足的问题。根据XR协会2024年发布的数据，30%的医疗服务提供者表示，他们对实施扩增实境计画的成本有疑虑。再加上报销政策不明朗，这种财务上的不确定性减缓了市场渗透，限制了患者获得身临其境型疗法的机会，并最终阻碍了整个领域的发展。

市场趋势

透过拓展至儿童和青少年治疗领域，市场正实现多元化发展，研发人员正针对弱视等疾病设计针对特定年龄层的介入措施。这项进步满足了年轻患者独特的发展需求，并将产业的应用范围从传统的成人復健领域扩展到更广泛的范围。透过利用身临其境型和互动式视觉环境，这些疗法能够提高那些难以用标准方法治疗的患者群体的治疗依从性。 2025年4月，BioSpace宣布Luminopia的虚拟实境疗法获得FDA批准，可用于8至12岁的儿童。这标誌着一个重要的里程碑，为美国约40万名弱视青少年提供了一种新的治疗选择，并凸显了该行业致力于拓展临床应用的决心。

同时，居家和远端医疗的兴起正在改变服务提供方式，使患者在临床环境之外也能获得持续的医疗服务。利用云端头戴装置即时追踪病患病情进展，使得身临其境型治疗扩充性。随着以使用者为中心的硬体设计不断进步，在患者家中实施治疗方案能够减轻医疗服务提供者的负担。根据《XR Today》杂誌（2025年2月刊）报道，XRHealth宣布其平台目前已被超过2,000名临床医师采用，并为超过5万名患者提供支援。这项数据得益于其对居家身临其境型医疗生态系统的策略性关注。这项发展也印证了远距VR治疗作为标准治疗方案的可行性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球虚拟实境在治疗领域的市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依技术分类（完全身临其境型VR、半身临其境型VR、非身临其境型VR）
  • 依设备类型（头戴式、手势控制、投影机）
  • 依应用领域（恐惧症治疗、机器人手术、视觉化、復健、创伤后压力症候群（PTSD）治疗、自闭症治疗、手术模拟）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美虚拟实境治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲虚拟实境在治疗领域的市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区虚拟实境在治疗领域的市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲虚拟实境在治疗领域的市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲虚拟实境在治疗领域的市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球虚拟实境治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Siemens AG
• Virtalis Holding Limited
• Vuzix Corporation
• Elevate Healthcare, Inc.
• Qualcomm Incorporated
• Virtual Realities, LLC
• Brainlab AG
• Surgical Science Sweden AB

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Virtual Reality in Therapy Market is projected to expand significantly, rising from a valuation of USD 3.31 Billion in 2025 to USD 7.47 Billion by 2031, reflecting a compound annual growth rate of 14.53%. This sector encompasses the utilization of immersive digital simulations to support physical rehabilitation, alleviate pain, and address mental health challenges like anxiety and PTSD. A primary catalyst for this growth is the escalating prevalence of chronic diseases, coupled with an urgent demand for scalable, non-invasive treatment options that can reduce the strain on conventional medical systems. Additionally, the increasing convergence of these immersive tools with telehealth infrastructures is improving patient accessibility and participation, establishing the technology as a crucial element of contemporary healthcare frameworks.

Despite this upward trajectory, the market faces notable impediments, particularly regarding the substantial expenses linked to procuring specialized hardware and engineering clinically verified software. These financial hurdles, along with complicated reimbursement structures, may retard adoption rates among smaller medical facilities. Nevertheless, confidence within the industry remains strong; the XR Association reported in 2024 that 84 percent of healthcare experts anticipate virtual and augmented reality technologies will effect a positive transformation within the sector. This pervasive optimism highlights the enduring value of immersive therapeutics, even amidst prevailing economic and operational challenges.

Market Driver

The market is being fundamentally transformed by an increase in clinical validations and regulatory endorsements, which are elevating virtual reality from a supplementary aid to a recognized medical intervention. As regulatory authorities define clearer approval pathways, medical practitioners are acquiring the assurance needed to prescribe immersive therapies for various applications, from surgical preparation to pain relief. This momentum is demonstrated by the growing number of sanctioned solutions; according to Radiology Business in September 2024, the U.S. FDA has authorized 69 medical products utilizing augmented or virtual reality, indicating a mature regulatory landscape that fosters broader acceptance. Such endorsements are essential for dispelling skepticism among clinicians and insurers, thereby hastening the incorporation of these devices into standard treatment protocols.

Furthermore, the surge in government grants and corporate investments in digital therapeutics is accelerating market expansion by enabling enterprises to enlarge their operations and advance their technological prowess. These financial infusions allow companies to combine assets, extend their clinical reach, and create advanced AI-driven capabilities for personalized care. For example, MedCity News reported in January 2024 that XRHealth obtained $6 million to facilitate its merger with Amelia Virtual Care and develop an AI-based clinician, establishing a comprehensive platform for physical and mental health. This capital is vital for running the extensive trials required to demonstrate efficacy and obtain reimbursement. Illustrating the clinical success fueling this investment, AppliedVR noted in 2024 that 70 percent of patients with high-impact chronic pain experienced a reduction in pain severity following treatment, emphasizing the concrete benefits these technologies provide.

Market Challenge

A major obstacle hindering the virtual reality in therapy market is the substantial expense involved in implementing specialized hardware and creating clinically validated software. Immersive therapeutic applications demand sophisticated head-mounted displays and robust computing capabilities to guarantee both effectiveness and patient safety, necessitating considerable initial capital outlays. For numerous independent clinics and smaller healthcare entities, these upfront costs are often prohibitive, effectively blocking access to these innovative tools. This financial burden is exacerbated by the ongoing resources needed to support and upgrade complex digital infrastructures, resulting in a landscape where primarily large, well-resourced institutions can feasibly adopt such technologies.

Consequently, these economic constraints directly limit the scalability of VR therapies throughout the wider healthcare ecosystem. This reluctance to invest is reflected in industry surveys regarding adoption hurdles. According to data from the XR Association in 2024, 30 percent of healthcare professionals cited specific concerns regarding the costs associated with deploying extended reality programs. When combined with ambiguous reimbursement policies, this financial anxiety retards the pace of market penetration and restricts patient access to immersive treatments, ultimately impeding the overall growth of the sector.

Market Trends

The market is diversifying through an expansion into pediatric and adolescent therapy sectors, with developers designing age-specific interventions for conditions such as amblyopia. This progression caters to the distinct developmental requirements of younger patients, extending the industry's reach beyond its traditional emphasis on adult rehabilitation. By leveraging immersive and interactive visual environments, these therapies enhance adherence in demographic groups that are often challenging to treat via standard methods. As reported by BioSpace in April 2025, Luminopia achieved FDA clearance to extend its virtual reality therapy to children between the ages of 8 and 12, a significant milestone that offers a new treatment avenue for roughly 400,000 young patients in the U.S. with amblyopia, highlighting the industry's dedication to broadening its clinical application.

Simultaneously, the shift toward home-based and remote care paradigms is transforming service delivery by facilitating continuous therapy outside of clinical environments. This evolution enables providers to track patient progress in real-time using cloud-enabled headsets, thereby enhancing the scalability of immersive treatments. As hardware becomes increasingly user-centric, the ability to administer therapeutic programs directly in patients' homes alleviates logistical pressures on medical facilities. According to XR Today in February 2025, XRHealth announced that its platform is now employed by over 2,000 clinicians to assist more than 50,000 patients, a statistic resulting from its strategic emphasis on a home-based immersive healthcare ecosystem. This rising utilization underscores the practicality of remote VR therapy as a recognized standard of care.

Key Market Players

• Siemens AG
• Virtalis Holding Limited
• Vuzix Corporation
• Elevate Healthcare, Inc.
• Qualcomm Incorporated
• Virtual Realities, LLC
• Brainlab AG
• Surgical Science Sweden AB

Report Scope

In this report, the Global Virtual Reality in Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virtual Reality in Therapy Market, By Technology

• Full Immersive VR
• Semi-Immersive VR
• Non- Immersive VR

Virtual Reality in Therapy Market, By Device

• Head Mount
• Gesture Control
• Projectors

Virtual Reality in Therapy Market, By Application

• Phobia Treatment
• Robotic Surgery
• Visualization
• Rehabilitation
• Treatment of Post-Traumatic Stress Disorder
• Treatment of Autism
• Surgery Simulation

Virtual Reality in Therapy Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Virtual Reality in Therapy Market.

Available Customizations:

Global Virtual Reality in Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virtual Reality in Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Full Immersive VR, Semi-Immersive VR, Non- Immersive VR)
  • 5.2.2. By Device (Head Mount, Gesture Control, Projectors)
  • 5.2.3. By Application (Phobia Treatment, Robotic Surgery, Visualization, Rehabilitation, Treatment of Post-Traumatic Stress Disorder, Treatment of Autism, Surgery Simulation)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Virtual Reality in Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Device
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virtual Reality in Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Device
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Virtual Reality in Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Device
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Virtual Reality in Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Device
      • 6.3.3.2.3. By Application

7. Europe Virtual Reality in Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Device
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Virtual Reality in Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Device
      • 7.3.1.2.3. By Application
  • 7.3.2. France Virtual Reality in Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Device
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Virtual Reality in Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Device
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Virtual Reality in Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Device
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Virtual Reality in Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Device
      • 7.3.5.2.3. By Application

8. Asia Pacific Virtual Reality in Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Device
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Virtual Reality in Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Device
      • 8.3.1.2.3. By Application
  • 8.3.2. India Virtual Reality in Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Device
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Virtual Reality in Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Device
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Virtual Reality in Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Device
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Virtual Reality in Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Device
      • 8.3.5.2.3. By Application

9. Middle East & Africa Virtual Reality in Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Device
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Virtual Reality in Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Device
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Virtual Reality in Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Device
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Virtual Reality in Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Device
      • 9.3.3.2.3. By Application

10. South America Virtual Reality in Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Device
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Virtual Reality in Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Device
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Virtual Reality in Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Device
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Virtual Reality in Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Device
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Virtual Reality in Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Siemens AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Virtalis Holding Limited
• 15.3. Vuzix Corporation
• 15.4. Elevate Healthcare, Inc.
• 15.5. Qualcomm Incorporated
• 15.6. Virtual Realities, LLC
• 15.7. Brainlab AG
• 15.8. Surgical Science Sweden AB

16. Strategic Recommendations

17. About Us & Disclaimer